Literature DB >> 25157429

On the relevance of the NPY2-receptor variation for modes of action cascading processes.

Christian Beste1, Ann-Kathrin Stock2, Jörg T Epplen3, Larissa Arning4.   

Abstract

Every day, we encounter situations in which we have to deal with multiple response options. In order not to overstrain response selection resources, we need to cascade the associated task goals. Yet, the neurobiological foundations of these action cascading processes are largely unknown. Aiming at determining the possible relevance of the neuropeptide Y Y2 receptor for action cascading processes, this study investigates a functional promoter variation (rs2234759) in the neuropeptide Y Y2 receptor gene (NPY2R). 176 healthy subjects completed a stop-change paradigm. Applying mathematical constraints to the obtained behavioral data allowed for a classification of the action cascading processing mode on a serial to parallel continuum. Neurophysiological data (EEG) were analyzed along this mathematical constraint. The behavioral data show that the Y2-receptor high expression G allele is associated with a less efficient mode of action cascading where different task goals are activated in parallel. The neurophysiological data indicate that this effect is based on modulations at the response selection stage but not on changes in the preceding attentional selection processes. Analyses show that the interrelation between behavioral and neurophysiological data is mediated by genotype effects. At the level of response selection, genotype effects are associated with activity changes in the anterior cingulate cortex (ACC). Changes in the reliability of neural synchronization processes in the theta frequency band are also related to these effects. Possibly, these Y2-receptor-related effects emerge from the receptor's strong interrelation with the dopamine system.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Action control; EEG; NPY2R; P3; Processing modes; Promoter variation

Mesh:

Substances:

Year:  2014        PMID: 25157429     DOI: 10.1016/j.neuroimage.2014.08.026

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  7 in total

1.  A causal role of the right inferior frontal cortex in implementing strategies for multi-component behaviour.

Authors:  Gabriel Dippel; Christian Beste
Journal:  Nat Commun       Date:  2015-04-08       Impact factor: 14.919

2.  The global clonal complexity of the murine blood system declines throughout life and after serial transplantation.

Authors:  Miguel Ganuza; Trent Hall; David Finkelstein; Yong-Dong Wang; Ashley Chabot; Guolian Kang; Wenjian Bi; Gang Wu; Shannon McKinney-Freeman
Journal:  Blood       Date:  2019-02-19       Impact factor: 22.113

3.  The importance of sensory integration processes for action cascading.

Authors:  Krutika Gohil; Ann-Kathrin Stock; Christian Beste
Journal:  Sci Rep       Date:  2015-03-30       Impact factor: 4.379

4.  Improvements of sensorimotor processes during action cascading associated with changes in sensory processing architecture-insights from sensory deprivation.

Authors:  Krutika Gohil; Anja Hahne; Christian Beste
Journal:  Sci Rep       Date:  2016-06-20       Impact factor: 4.379

5.  Neural mechanisms underlying successful and deficient multi-component behavior in early adolescent ADHD.

Authors:  Annet Bluschke; Krutika Gohil; Maxi Petzold; Veit Roessner; Christian Beste
Journal:  Neuroimage Clin       Date:  2018-02-27       Impact factor: 4.881

6.  Action Video Gaming and Cognitive Control: Playing First Person Shooter Games Is Associated with Improved Action Cascading but Not Inhibition.

Authors:  Laura Steenbergen; Roberta Sellaro; Ann-Kathrin Stock; Christian Beste; Lorenza S Colzato
Journal:  PLoS One       Date:  2015-12-10       Impact factor: 3.240

7.  Conscientiousness increases efficiency of multicomponent behavior.

Authors:  Ann-Kathrin Stock; Christian Beste
Journal:  Sci Rep       Date:  2015-10-27       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.